Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. (Q51783087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

hypertrophic cardiomyopathy

20 December 2019

main subject

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Stephen W Luckey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jason Mansoori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Kelly Fair

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Christopher L Antos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Eric N Olson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

29 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology Heart and Circulatory Physiology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

H838-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17012357%20AND%20SRC:MED&resulttype=core&format=json

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Gender modulates cardiac phenotype development in genetically modified mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

A mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Negative regulators of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Sex modifies exercise and cardiac adaptation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Sex is a potent modifier of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Phospholamban: a crucial regulator of cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

The molecular genetic basis for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Remodeling the cardiac sarcomere using transgenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Hypertrophy, pathology, and molecular markers of cardiac pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006

Sex Hormones and Cardiomyopathic Phenotype Induced by Cardiac β2-Adrenergic Receptor Overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00615.2006